Literature DB >> 8918830

The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation.

T S Zorick1, D E Syroid, E Arroyo, S S Scherer, G Lemke.   

Abstract

We have studied the transcription factors SCIP and Krox-20 in differentiating Schwann cells-during normal development, in experimentally induced degenerating and regenerating peripheral nerves, and in cell culture-and have compared the expression of these regulators to a battery of genes that mark distinct stages in Schwann cell differentiation. In the myelinating Schwann cell lineage, we find that SCIP is initially induced by contact with axons and first appears near the last round of cell division in immature cells. This expression is transient--it is maximal in "promyelinating" cells and is then extinguished as Schwann cells overtly differentiate and myelinate axons. In contrast, Krox-20 appears in cells 24-36 h after they become SCIP+ and continues to be expressed in mature myelinating cells. These differences in regulation are seen in normal development, in regenerating nerves following nerve crush, and in cultured Schwann cells stimulated to adopt a myelination phenotype by elevation of intracellular cyclic AMP. Importantly, transient SCIP expression is also observed in the nonmyelinating Schwann cell lineage, but Krox-20 expression is not. Together with the myelination phenotypes exhibited by SCIP and Krox-20 mutant mice, these results suggest that SCIP preferentially acts during the predifferentiated phases of Schwann cell development, while in contrast, Krox-20 is associated with the later commitment to myelination and may therefore function as a direct transactivator of myelination genes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8918830     DOI: 10.1006/mcne.1996.0052

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  63 in total

1.  Protein zero gene expression is regulated by the glial transcription factor Sox10.

Authors:  R I Peirano; D E Goerich; D Riethmacher; M Wegner
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  A distal Schwann cell-specific enhancer mediates axonal regulation of the Oct-6 transcription factor during peripheral nerve development and regeneration.

Authors:  W Mandemakers; R Zwart; M Jaegle; E Walbeehm; P Visser; F Grosveld; D Meijer
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

3.  A cell type-specific allele of the POU gene Oct-6 reveals Schwann cell autonomous function in nerve development and regeneration.

Authors:  Merhnaz Ghazvini; Wim Mandemakers; Martine Jaegle; Marko Piirsoo; Siska Driegen; Manousos Koutsourakis; Xsander Smit; Frank Grosveld; Dies Meijer
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

4.  The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation.

Authors:  Marie C Harrisingh; Elena Perez-Nadales; David B Parkinson; Denise S Malcolm; Anne W Mudge; Alison C Lloyd
Journal:  EMBO J       Date:  2004-07-08       Impact factor: 11.598

5.  Developmental regulation of microRNA expression in Schwann cells.

Authors:  Nolan G Gokey; Rajini Srinivasan; Camila Lopez-Anido; Courtney Krueger; John Svaren
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

Review 6.  Glial cells: old cells with new twists.

Authors:  Ugo Ndubaku; Maria Elena de Bellard
Journal:  Acta Histochem       Date:  2007-12-18       Impact factor: 2.479

Review 7.  Laminins in peripheral nerve development and muscular dystrophy.

Authors:  Wei-Ming Yu; Huaxu Yu; Zu-Lin Chen
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

8.  Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice.

Authors:  Agnes Patzkó; Yunhong Bai; Mario A Saporta; István Katona; Xingyao Wu; Domenica Vizzuso; M Laura Feltri; Suola Wang; Lisa M Dillon; John Kamholz; Daniel Kirschner; Fazlul H Sarkar; Lawrence Wrabetz; Michael E Shy
Journal:  Brain       Date:  2012-12       Impact factor: 13.501

9.  Active gene repression by the Egr2.NAB complex during peripheral nerve myelination.

Authors:  Gennifer M Mager; Rebecca M Ward; Rajini Srinivasan; Sung-Wook Jang; Lawrence Wrabetz; John Svaren
Journal:  J Biol Chem       Date:  2008-05-02       Impact factor: 5.157

10.  Variation in SIPA1L2 is correlated with phenotype modification in Charcot- Marie- Tooth disease type 1A.

Authors:  Feifei Tao; Gary W Beecham; Adriana P Rebelo; John Svaren; Susan H Blanton; John J Moran; Camila Lopez-Anido; Jasper M Morrow; Lisa Abreu; Devon Rizzo; Callyn A Kirk; Xingyao Wu; Shawna Feely; Camiel Verhamme; Mario A Saporta; David N Herrmann; John W Day; Charlotte J Sumner; Thomas E Lloyd; Jun Li; Sabrina W Yum; Franco Taroni; Frank Baas; Byung-Ok Choi; Davide Pareyson; Steven S Scherer; Mary M Reilly; Michael E Shy; Stephan Züchner
Journal:  Ann Neurol       Date:  2019-03       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.